MUC1 is overexpressed in 75–90% of human EOC and, interestingly, tumor-associated MUC1 is more immunogenic because of the loss of glycosylation, revealing epitopes that can be targeted by antibodies and specific CD8+ T cell responses [175,176,177]. The gene discussed is MUC1; the disease is neoplasm.